Gene · 915
Papers3,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Differential phagocytosis induces diverse macrophage activation states in malignant gliomas. | J Immunother Cancer | 2025 | 40912739 | PubTator, text mining | PubMed |
| Recent Advances in Deciphering Normal and Diseased Aortic Valve Biology Using Transcriptomic Technologies. | J Cell Mol Med | 2025 | 40903834 | PubTator, text mining | PubMed |
| YRDC is a Prognostic-Related Biomarker Correlated With Immune Infiltration and Drug Sensitivity in Pan-Cancer. | Cancer Rep (Hoboken) | 2025 | 40898423 | PubTator, text mining | PubMed |
| Evaluating the causal effect of circulating proteome on the risk of Juvenile idiopathic arthritis: an omics pipeline study. | Pediatr Rheumatol Online J | 2025 | 40898345 | PubTator, text mining | PubMed |
| T cell exhaustion‑related gene CD79B predicts prognosis, inhibits malignant progression and promotes tumor‑associated macrophage M1‑like polarization in lung adenocarcinoma. | Oncol Rep | 2025 | 40878933 | PubTator, text mining | PubMed |
| Integrated analysis of m6A regulator mediated RNA methylation and key immune related genes in ischemic stroke. | Sci Rep | 2025 | 40877397 | PubTator, text mining | PubMed |
| Clonal diversity shapes the tumour microenvironment leading to distinct immunotherapy responses in metastatic urothelial carcinoma. | Nat Commun | 2025 | 40866351 | PubTator, text mining | PubMed |
| DECIPHER for learning disentangled cellular embeddings in large-scale heterogeneous spatial omics data. | Nat Commun | 2025 | 40866331 | PubTator, text mining | PubMed |
| Tumor Immune Response as a Biomarker for Metastasis-Free Survival of Breast Cancer and Immune Checkpoint Inhibition Therapy: A Retrospective Cohort Study. | Breast Cancer (Auckl) | 2025 | 40860292 | PubTator, text mining | PubMed |
| Reprogramming the tumor microenvironment with c-MYC-based gene circuit platform to enhance specific cancer immunotherapy. | Nat Commun | 2025 | 40858620 | PubTator, text mining | PubMed |
| Investigating cytotoxic and inflammatory human IL-7 receptor low effector memory CD8+ T cells in lupus. | EBioMedicine | 2025 | 40857939 | PubTator, text mining | PubMed |
| Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4-/- mice. | Hepatol Commun | 2025 | 40857400 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals Effects of Long-Term Contact Lens Wearing on the Human Corneal Epithelium. | Invest Ophthalmol Vis Sci | 2025 | 40856653 | PubTator, text mining | PubMed |
| NAD+ Metabolism-Mediated SURF4-STING Axis Enhances T-Cell Anti-Tumor Effects in the Ovarian Cancer Microenvironment. | Cell Death Dis | 2025 | 40846839 | PubTator, text mining | PubMed |
| Molecular characterization and prognostic implications of KRAS mutations in pancreatic cancer patients: insights from multi-cohort analysis. | NPJ Precis Oncol | 2025 | 40846754 | PubTator, text mining | PubMed |
| Multiomics integration analysis identifies tumor cell-derived MIF as a therapeutic target and potentiates anti-PD-1 therapy in osteosarcoma. | J Immunother Cancer | 2025 | 40846326 | PubTator, text mining | PubMed |
| Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model. | Discov Oncol | 2025 | 40835789 | PubTator, text mining | PubMed |
| DNA Methylation Biomarkers Predict Offspring Metabolic Risk From Mothers With Hyperglycemia in Pregnancy. | Diabetes | 2025 | 40834241 | PubTator, text mining | PubMed |
| Identifying therapeutic targets for erectile dysfunction in the European population using genome-wide Mendelian randomization. | Sex Med | 2025 | 40831791 | PubTator, text mining | PubMed |
| Anoikis-related genes predicts prognosis and therapeutic response in renal cell carcinoma. | Ann Med | 2025 | 40830065 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/915/papers?page=6